China (Mainland)
Tenofovir Alafenamide Fumarate API CAS NO.1392275-56-7
- Min.Order: 1 Kilogram
- Payment Terms: T/T
- Product Details
Keywords
- Tenofovir
- 99% Tenofovir
- 99% Tenofovir API
Quick Details
- ProName: Tenofovir Alafenamide Fumarate API
- CasNo: 1392275-56-7
- Molecular Formula: C46H62N12O14P2
- Appearance: white powder
- Application: finished formulation R&D
- DeliveryTime: based on the order
- PackAge: drum or as required
- Port: Shanghai
- ProductionCapacity: 100 Kilogram/Month
- Purity: 99%
- Storage: room temperature
- Transportation: by sea or by air
- LimitNum: 1 Kilogram
- Valid Period: 24 months
Superiority
API grade
GMP available
Registration support
Bocimed does not sell compounds in the period of patent protection. According to the relevant provisions of the patent law, "the act of importing, manufacturing and using patented drugs by others before the expiration of drug patents without the consent of the patentee in order to obtain the data and other information required by the drug administration department shall be not regarded as infringing the patent right".
Details
product name: Tenofovir Alafenamide Fumarate API
CAS 1392275-56-7
Purity ≥ 99%
Shanghai Bocimed Pharmaceutical Co., Ltd. is a technology enterprise specializing in pharmaceutical research, which was established in Zhangjiang Pharmaceutical Valley of Shanghai in 2012. Bocimed has Zhangjiang R & D headquarter, Lingang production base and Chengdu clinical subsidiary. With the unique platform advantages of solubilization technology, sustained-release technology and nanotechnology, the company is committed to become a leading enterprise in the development and production of innovative and special preparations, and realize the vision of bringing better drugs to the world.
Bocimed does not sell compounds in the period of patent protection. According to the relevant provisions of the patent law, "the act of importing, manufacturing and using patented drugs by others before the expiration of drug patents without the consent of the patentee in order to obtain the data and other information required by the drug administration department shall be not regarded as infringing the patent right".
Bocimed does not sell compounds in the period of patent protection. According to the relevant provisions of the patent law, "the act of importing, manufacturing and using patented drugs by others before the expiration of drug patents without the consent of the patentee in order to obtain the data and other information required by the drug administration department shall be not regarded as infringing the patent right".